Trial Profile
A randomised, controlled trial to assess efficacy and safety of adjunctive TachoSil with current practice for the prevention of postoperative CSF leaks in patients undergoing elective skull base surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2018
Price :
$35
*
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- 17 Jan 2018 New trial record